IL104189A - Controlled release device of drug extract - Google Patents

Controlled release device of drug extract

Info

Publication number
IL104189A
IL104189A IL10418992A IL10418992A IL104189A IL 104189 A IL104189 A IL 104189A IL 10418992 A IL10418992 A IL 10418992A IL 10418992 A IL10418992 A IL 10418992A IL 104189 A IL104189 A IL 104189A
Authority
IL
Israel
Prior art keywords
core
polymer
coating
apertures
hydration
Prior art date
Application number
IL10418992A
Other languages
English (en)
Hebrew (he)
Other versions
IL104189A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL104189A0 publication Critical patent/IL104189A0/xx
Publication of IL104189A publication Critical patent/IL104189A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10418992A 1991-12-27 1992-12-21 Controlled release device of drug extract IL104189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (2)

Publication Number Publication Date
IL104189A0 IL104189A0 (en) 1993-05-13
IL104189A true IL104189A (en) 1996-10-31

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10418992A IL104189A (en) 1991-12-27 1992-12-21 Controlled release device of drug extract

Country Status (26)

Country Link
EP (1) EP0549331B1 (fr)
JP (1) JPH089534B2 (fr)
KR (1) KR100281609B1 (fr)
CN (1) CN1074368A (fr)
AT (1) ATE157001T1 (fr)
AU (1) AU660057B2 (fr)
BG (1) BG61751B1 (fr)
CA (1) CA2085871C (fr)
CZ (1) CZ284045B6 (fr)
DE (1) DE69221711T2 (fr)
DK (1) DK0549331T3 (fr)
ES (1) ES2106838T3 (fr)
FI (1) FI109451B (fr)
GR (1) GR3024885T3 (fr)
HU (1) HU219594B (fr)
IL (1) IL104189A (fr)
LV (1) LV12082B (fr)
MX (1) MX9207541A (fr)
NO (1) NO310672B1 (fr)
NZ (1) NZ245514A (fr)
PL (1) PL171110B1 (fr)
RO (1) RO112810B1 (fr)
RU (1) RU2127586C1 (fr)
SK (1) SK279964B6 (fr)
WO (1) WO1993012765A1 (fr)
YU (1) YU48762B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
IL130872A (en) * 1997-01-14 2004-02-19 Lohmann Therapie Syst Lts Device for controlled release of active compounds in the connection of the stomach and intestines containing an expanding component
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
WO2000062759A1 (fr) 1999-04-16 2000-10-26 Novo Nordisk A/S Formulation pharmaceutique seche et moulable
US6861071B2 (en) * 2000-08-08 2005-03-01 Daiichi Pharmaceutical Co., Ltd. Highly absorptive solid preparation
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
EP1458352A1 (fr) * 2001-12-18 2004-09-22 Novo Nordisk A/S Micro implant a dose solide
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
RU2005108609A (ru) * 2002-09-28 2006-03-10 МакНЕЙЛ-ППС, ИНК. (US) Лекарственные формы с модифицированным высвобождением, имеющие два ядра и отверстие
WO2004108067A2 (fr) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Systeme de distribution de medicaments programme
AU2005269988B2 (en) 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
NZ572193A (en) 2006-03-31 2011-10-28 Quadra Logic Tech Inc Nasolacrimal drainage system implants for drug therapy with non-fluid swellable retention structure around drug core
BRPI0817074A2 (pt) 2007-09-07 2015-03-24 Qlt Plug Delivery Inc Aparelho, método para tratar uma desordem ocular, dispositivo de detecção e sistema de detecção
CN103889401B (zh) 2011-08-29 2017-10-13 Qlt公司 持续释放递送活性剂以治疗青光眼和高眼压
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
IL104189A0 (en) 1993-05-13
MX9207541A (es) 1994-06-30
SK279964B6 (sk) 1999-06-11
RO112810B1 (ro) 1998-01-30
WO1993012765A1 (fr) 1993-07-08
NZ245514A (en) 1994-12-22
FI943011A0 (fi) 1994-06-22
LV12082A (lv) 1998-07-20
GR3024885T3 (en) 1998-01-30
EP0549331B1 (fr) 1997-08-20
AU3034892A (en) 1993-08-12
PL171110B1 (pl) 1997-03-28
YU48762B (en) 1999-11-22
CN1074368A (zh) 1993-07-21
DK0549331T3 (da) 1997-09-15
BG98805A (bg) 1995-03-31
CZ157094A3 (en) 1994-12-15
FI109451B (fi) 2002-08-15
KR940703653A (ko) 1994-12-12
HU219594B (hu) 2001-05-28
ATE157001T1 (de) 1997-09-15
CZ284045B6 (cs) 1998-07-15
ES2106838T3 (es) 1997-11-16
NO942430D0 (no) 1994-06-27
DE69221711T2 (de) 1998-03-12
DE69221711D1 (de) 1997-09-25
YU111292A (sh) 1995-12-04
CA2085871C (fr) 2002-05-07
JPH05255071A (ja) 1993-10-05
AU660057B2 (en) 1995-06-08
HU9401913D0 (en) 1994-09-28
SK76994A3 (en) 1995-05-10
LV12082B (en) 1998-09-20
NO310672B1 (no) 2001-08-13
HUT70437A (en) 1995-10-30
JPH089534B2 (ja) 1996-01-31
KR100281609B1 (ko) 2001-02-15
FI943011A (fi) 1994-06-22
CA2085871A1 (fr) 1993-06-28
NO942430L (no) 1994-06-27
BG61751B1 (bg) 1998-05-29
EP0549331A1 (fr) 1993-06-30
RU2127586C1 (ru) 1999-03-20
RU94031474A (ru) 1997-04-20

Similar Documents

Publication Publication Date Title
US5366738A (en) Controlled release drug dispersion delivery device
US5543154A (en) Controlled release nifedipine delivery device
US5582838A (en) Controlled release drug suspension delivery device
EP0549331B1 (fr) Dispositif pour l'administration de dispersions médicamenteuses à libération contrÔlée
MXPA97004672A (en) Device supplier of suspension of farmaco, control deliberation
US5869097A (en) Method of therapy comprising an osmotic caplet
US5256440A (en) Process for producing a tablet core aperture
US8535717B2 (en) Pharmaceutical composition
CA2206211C (fr) Dispositif de liberation controlee d'une suspension medicamenteuse

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees